Tamtam Try Tamtam free
Clariane logo

Clariane account plan

European care community leader

At a glance

Clariane (formerly Korian) runs 1,215 nursing homes, clinics and care sites in six European countries: €5,310m FY2025 revenue, 70,685 employees.

Clariane SE, formerly Korian and renamed in 2023 when it became a purpose-driven company, is a European specialist in non-acute care: medicalised nursing homes, specialty and mental health clinics, and alternative living and home-based care. At 31 December 2025 it ran 1,215 facilities with about 89,400 beds in France, Germany, Belgium, the Netherlands, Italy and Spain, employed 70,685 people (65,034 FTEs) and cared for 842,566 patients and residents. FY2025 revenue was €5,310m (+4.5% organic), EBITDA excl. IFRS 16 €594m and attributable net profit excl. IFRS 16 €36m. Revenue is mainly regulated, with a care portion funded by public payers. It is listed on Euronext Paris; Predica (Crédit Agricole Assurances) and HLD Europe each hold over 10% of capital.

Business units

Strategic priorities

Succeeding Together plan 2025-2028
Revenue CAGR around 4%, pre-IFRS 16 EBITDA CAGR 7-9%, opco EBITDA CAGR 11-14% and Wholeco leverage around 5x at end-2028 (adjusted in July 2026 from around 4.5x), self-financed.
Margin recovery
Boissard says margin recovery is set to continue in 2026, driven by performance plans particularly in Germany and France; pre-IFRS 16 EBITDA margin reached 10.4% in H1 2026.
Care closer to home and outpatient
Strategy pillars include personalised care closer to home and the shift to outpatient models; outpatient revenue in France grew 16% in 2025.
Talent and training
Clariane University ran more than 863,000 training hours in 2025 with 7,743 employees on qualifying training paths, and aims for 75% of facility directors promoted from within by end-2026.
Quality of care
Targets include an NPS of at least 40 (+45 in 2025) and a lost-time accident frequency rate of 29 (28 in 2025); 99% of nursing homes and clinics are ISO 9001 certified.
Digital, AI and geroscience
Boissard names the technology shift as a priority to 2029, with a dedicated team working with digital and AI experts, alongside geroscience and prevention.

Latest results

In H1 2026 revenue was €2,699m, +1.6% reported and +4.6% organic (volumes +1.6%, price +3.0%, scope -3.0% from the 2025 disposals). Pre-IFRS 16 EBITDA rose 14.9% pro forma to €280m (margin 10.4% vs 9.5%) and opco EBITDA 25.1% pro forma to €168m. Nursing home occupancy reached 91.7% (90.5%). The attributable net loss was €48m (IFRS) after €51m of non-recurring costs and €100m of financial expenses. Net financial debt fell to €3,020m and liquidity rose to €1,736m. The 2023-2026 and 2025-2028 targets were confirmed, with leverage targets adjusted to below 5.5x at end-2026 and around 5x at end-2028.

Investments and deals

€1bn disposal programme completed
The €1.5bn plan to strengthen the financial structure was completed in June 2025, six months early, ending with the sale of Petits-fils (€345m enterprise value) at an average EBITDA multiple of around 14x.
Bond refinancing
In H1 2026 Clariane raised more than €1bn in bonds: €730m 6.875% senior notes due 2031 and a €333m 7.875% hybrid, after first ratings of B+ (S&P) and B2 (Moody's).
Capex programme
Capex of about €300m a year, split evenly between maintenance and development; 33 facilities opened over the 12 months to June 2026.
Real estate sale and leaseback
Nine Belgian buildings sold to Care Property Invest in December 2025 (€143m total) with 20-year leases; the real estate portfolio was valued at €2,428m in H1 2026.
France support-function plan
A 2026 plan cut 71 net jobs in French support functions, centralising accounting in Aix-en-Provence and closing the Devecey site.

Challenges and risks

Regulated pricing reforms
The French SMR financing reform caused pricing anomalies and underfunding of facilities opened 2023-2025, corrected by the authorities in H2 2025.
Recruitment and labour costs
Labour costs are 61% of revenue, and recruitment and retention of trained care staff is a key risk across all facilities.
Leverage and covenants
Net debt excl. IFRS 16 was €3,055m at end-2025, and no dividend is paid while Wholeco leverage is above 4.0x; the covenant was reset to 7.5x at 30 June 2026.
Quality of care and reputation
Falls, malnutrition, abuse, fire and legionellosis are named operational risks, along with reputational damage to the sector.
Cybersecurity and data
IT, cybersecurity and personal data protection are listed among the operational risks.

What leadership says

“Margin recovery is set to continue and intensify in 2026, driven by the various performance plans under way, particularly in Germany and France.”

Sophie Boissard, CEO · 2025 Universal Registration Document, February 2026

“The first-half results reflect the sound execution of our roadmap and confirm the solidity of our fundamentals and our embedded growth potential.”

Sophie Boissard, CEO · 2026 Half-Year Financial Report, 29 July 2026

“growth prospects, improving the quality of care, developing our workforce and stabilising the Group's financial situation”

Sylvia Metayer, Chair of the Board · 2025 Universal Registration Document, on the board's focus

Where a supplier can help

Staffing and training tools
With labour at 61% of revenue and recruitment a key risk, workforce scheduling, recruitment and training solutions support the talent priority.
Care-quality and digital health
The digital, AI and geroscience priority and quality targets (NPS, falls, malnutrition) suit care-documentation, monitoring and fall-prevention technology.
Shared services and finance automation
Centralising French accounting in Aix-en-Provence and the margin recovery plans open room for finance automation and procurement tools.
Facilities and energy
About €300m of yearly capex, renovations and energy-emission targets fit construction, maintenance and energy-efficiency suppliers.
Cybersecurity for care sites
Cybersecurity and personal data are named risks across about 1,200 facilities, an opening for security and data-protection vendors.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Clariane?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Clariane

What does Clariane do?

Clariane, formerly Korian, runs medicalised nursing homes, specialty and mental health clinics, and alternative living and home care in France, Germany, Belgium, the Netherlands, Italy and Spain.

What was Clariane's revenue in 2025?

FY2025 revenue was €5,310m, +4.5% organic, with EBITDA excl. IFRS 16 of €594m. H1 2026 revenue was €2,699m.

How many employees does Clariane have?

70,685 employees (65,034 FTEs) at 31 December 2025.

What is Clariane's strategy?

The 2025-2028 Succeeding Together plan targets revenue growth around 4% a year and opco EBITDA growth of 11-14%, through occupancy, pricing, outpatient care and alternative living, while reducing leverage.

Who leads Clariane?

Sophie Boissard has been CEO since 2016, and Sylvia Metayer has chaired the board since 14 May 2025.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)